NCT02378155View on ClinicalTrials.gov

Cerebral Oxygen Saturation Measurement During Cardioversion Because of Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

June 30, 2015

Conditions
Electrical Cardioversion of Atrial FibrillationPharmacological Cardioversion of Atrial Fibrillation
Interventions
DEVICE

SenSmart Model X-100, Nonin Medical

Device to measure cerebral tissue oxygen saturation

Trial Locations (1)

3600

Ziekenhuis Oost-Limburg, Genk

All Listed Sponsors
lead

Hasselt University

OTHER

NCT02378155 - Cerebral Oxygen Saturation Measurement During Cardioversion Because of Atrial Fibrillation | Biotech Hunter | Biotech Hunter